NCT05691504 2026-03-19Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial CancersNational Cancer Institute (NCI)Phase 1 Recruiting42 enrolled
NCT07428486 2026-02-23A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic LeukemiaM.D. Anderson Cancer CenterPhase 1 Not yet recruiting24 enrolled